Rockefeller Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $261K | Sell |
|
|||||
|
2025
Q2 | $1.1M | Sell |
|
|||||
|
2025
Q1 | $2.05M | Buy |
|
|||||
|
2024
Q4 | $1.91M | Buy |
|
|||||
|
2024
Q3 | $439K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $212K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $18K | Sell |
|
|||||
|
2022
Q3 | $77K | Buy |
|
|||||
|
2022
Q2 | $48K | Sell |
|
|||||
|
2022
Q1 | $90K | Buy |
|
|||||
|
2021
Q4 | $178K | Buy |
|
|||||
|
2021
Q3 | $47K | Buy |
|
|||||
|
2021
Q2 | $36K | Buy |
|